3Botulism Handbook for epidemiologists, clincians, and laboratory workers[M]. CDC, 1998.
4Kozaki S, Kamata Y, Nishiki T, et al. Characterization of clostridium type B neurotoxin associated with infant botulism in Japan[J]. Infect Immum, 1998, 66( 10): 4811-4816.
5Puig de Centorbi O, Centorbi H J, Demo N, et al. Infant botulism, during a one year period in San Luris, Argentina[J]. Zentralbl Bateriol, 1998,287( 1 ).- 61-66.
6Bohnel H, Behrens S, Loch P, et al. Is there a link between infant botulism and sudden in death Bacteriological results ob- tained in central Germany[J]. Eur J Pediater, 2001,160( 10)- 623-628.
7Schiavo G, Matteoli M, Montecucco C. Neurotoxins affect- ing neuroexocytosis[J].Physiol Rev, 2000, 80(2): 717.
8Kathryn Turton, Chaddock J A, Acharya K R. Botulinum and tetanus neurotoxin: structure, function and therapeutic utility[J], rends in Biochemical Sciences, 2002,27( 11 ): 552-558.
9Dertzbaugh M T, West M W. Mapping of protective and cross-reactive domains of the type A neurotoxin of Clostridium botulinum[J]. Vaccine, 1996, 14( 16): 1538-1544.
10Hanson M A, Stevens R C. Cocrystal structure of synap- tobrevin-II bound to botulinum neurotoxin type B at 2.0 Ang- strom resolution[J]. Nat Struct Biol, 2000, 7(8): 687-692.
